Laboratoires Servier, a prominent French pharmaceutical company, is headquartered in Suresnes, France. Founded in 1954, Servier has established itself as a key player in the global healthcare industry, with a strong presence in Europe, Asia, and Africa. The company focuses on innovative treatments in various therapeutic areas, including cardiology, diabetes, oncology, and neurology. Servier is renowned for its commitment to research and development, investing significantly in new drug discovery and development. Its core products, such as the antihypertensive medication Perindopril, exemplify the company's dedication to improving patient outcomes through unique formulations and comprehensive treatment solutions. With a robust portfolio and a reputation for quality, Laboratoires Servier continues to strengthen its market position, achieving notable milestones in both innovation and patient care.
How does Laboratoires Servier's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Laboratoires Servier's score of 42 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Laboratoires Servier reported total greenhouse gas emissions of approximately 69,691,000 kg CO2e for Scope 1 and 33,300,000 kg CO2e for Scope 2, resulting in a combined total of about 102,991,000 kg CO2e for these scopes. In 2022, the company’s total emissions were significantly higher at approximately 1,170,000,000 kg CO2e, with Scope 1 emissions at about 77,597,000 kg CO2e, Scope 2 at 37,692,000 kg CO2e, and a substantial Scope 3 contribution of approximately 1,053,000,000 kg CO2e. Laboratoires Servier has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 GHG emissions by 25% by 2030, using 2016 as the base year. Additionally, the company targets a 25% reduction in Scope 3 emissions from capital goods, waste generated in operations, business travel, and employee commuting, as well as a 21% reduction in Scope 3 emissions from downstream transportation and distribution by the same deadline. Furthermore, Servier has committed to ensuring that key suppliers, representing 52% of emissions from purchased goods and services, will establish science-based targets for Scope 1 and 2 emissions by 2024. These initiatives reflect Servier's commitment to aligning with industry standards for climate action and contribute to the broader goal of limiting global warming to 2°C.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Scope 1 | 62,044,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 54,578,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | 0,000,000,000 | - | - | 0,000,000,000 | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laboratoires Servier is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.